For the Inventor, By the Inventor

Enter assignee name

Dublin, Ireland

Alkermes Pharma Ireland Limited

USPTO Granted Patents = 160

CIPO Patents = 9

EPO Patents = 45

Trademarks = 20

Forward Citations = 1,164

Loading Chart...

Loading Chart...

118 inventors (with patents filed for the assignee):

Tarek A Zeidan (47 out of 47 patents)

Daniel R Deaver (40 out of 49 patents)

Laura Cook Blumberg (37 out of 51 patents)

4. Julius F Remenar (37 out of 52 patents)

5. Thomas Andrew Wynn (28 out of 30 patents)

6. Magali B Hickey (24 out of 28 patents)

7. Jennifer Vandiver (20 out of 20 patents)

8. Jason M Perry (17 out of 20 patents)

9. Scott M Duncan (16 out of 37 patents)

10. Christopher P Hencken (16 out of 18 patents)

11. Steven G Wright (16 out of 42 patents)

12. Carlos N Sanrame (14 out of 14 patents)

13. Joyce M Hotz (13 out of 30 patents)

14. Mark Todtenkopf (11 out of 13 patents)

15. Orn Almarsson (10 out of 22 patents)

Core Competencies:

Immediate Release Multilayer Tablet

Pharmaceutical Compositions

Prodrugs of Fumarates

Aripiprazole Formulations

Antipsychotic-Induced Weight Gain

Heterocyclic Compounds

Neurological Disorders

Psychological Disorders

Sustained Release Composition

Cancer Immunotherapy

Immunomodulatory Agents

Long-Acting Injectable Compositions

160 patents: Sort by Forward Citations

1. 12390474 - Immediate release multilayer tablet (2025-08-19),

2. 12311027 - Pharmaceutical compositions having improved storage stability (2025-05-27),

3. 12257249 - Methods for treating depressive symptoms (2025-03-25),

4. 12251381 - Aripiprazole dosing strategy (2025-03-18),

5. 12194035 - Methods for treating antipsychotic-induced weight gain (2025-01-14),

6. 12180164 - Heterocyclic compounds for the treatment of neurological and psychological disorders (2024-12-31),

7. 12076306 - Prodrugs of fumarates and their use in treating various diseases (2024-09-03),

8. 11969469 - Pharmaceutical compositions having improved storage stability (2024-04-30),

9. 11951111 - Immediate release multilayer tablet (2024-04-09),

10. 11931355 - Aripiprazole formulations having increased injection speeds (2024-03-19),

11. 11905298 - Prodrugs of fumarates and their use in treating various diseases (2024-02-20),

12. 11883394 - Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia (2024-01-30),

13. 11834483 - Immunostimulatory agents in combination with angiogenesis inhibitors (2023-12-05),

14. 11793805 - Methods for treating antipsychotic-induced weight gain (2023-10-24),

15. 11786514 - Sustained release aminopyridine composition (2023-10-17),

Alkermes Pharma Ireland Limited is a global biopharmaceutical company that focuses on developing innovative medicines to address unmet medical needs in the fields of psychiatry, neurology, and oncology. With a diverse portfolio of therapeutics and a commitment to advancing scientific research, Alkermes is dedicated to improving patient outcomes and transforming the lives of individuals with complex diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

160 Patents

#13 in Dublin

#18 in Ireland

#5,010 in the World

Dublin, Ireland

Alkermes Pharma Ireland Limited

Forward Citations = 1,164

118 inventors:

Tarek A Zeidan (47 out of 47 patents)

Daniel R Deaver (40 out of 49 patents)

Laura Cook Blumberg (37 out of 51 patents)

4. Julius F Remenar (37 out of 52 patents)

5. Thomas Andrew Wynn (28 out of 30 patents)

Please report any incorrect information to support@idiyas.com

Loading…